CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
157232-64-9 | Cereulide (9CI); 1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.; Cyclo(D-alanyl-3-methyl-L-2-hydroxybutanoyl-L-valyl-4-methyl-D-2-hydroxypentanoyl-D-alanyl-3-methyl-L-2-hydroxybutanoyl-L-valyl-4-methyl-D-2-hydroxypentanoyl-D-alanyl-3-methyl-L-2-hydroxybutanoyl-L-valyl-4-methyl-D-2-hydroxypentanoyl) | C57H96N6O18 | 详情 | 供应商 | ||
31616-94-1 | enantio-Valinomycin(8CI,9CI); 1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.; Cyclo(L-a-hydroxyisovaleryl-L-valyl-D-lactoyl-D-valyl-L-a-hydroxyisovaleryl-L-valyl-D-lactoyl-D-valyl-L-a-hydroxyisovaleryl-L-valyl-D-lactoyl-D-valyl) | C54H90N6O18 | 详情 | 供应商 | ||
31616-97-4 | enantio-pseudo-retro-Valinomycin(8CI,9CI); 1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.; Cyclo(D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl); Cyclo(D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl) | C54H90N6O18 | 详情 | 供应商 | ||
31616-95-2 | enantio-retro-Valinomycin(8CI,9CI); 1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.; Cyclo(L-a-hydroxyisovaleryl-D-valyl-D-lactoyl-L-valyl-L-a-hydroxyisovaleryl-D-valyl-D-lactoyl-L-valyl-L-a-hydroxyisovaleryl-D-valyl-D-lactoyl-L-valyl) | C54H90N6O18 | 详情 | 供应商 | ||
170034-95-4 | Homocereulide (9CI); Cyclo(D-alanyl-3-methyl-L-2-hydroxybutanoyl-L-valyl-4-methyl-D-2-hydroxypentanoyl-D-alanyl-3-methyl-L-2-hydroxybutanoyl-L-valyl-4-methyl-D-2-hydroxypentanoyl-D-alanyl-erythro-3-methyl-L-2-hydroxypentanoyl-D-valyl-4-methyl-D-2-hydroxypentanoyl) | C58H98N6O18 | 详情 | 供应商 | ||
31518-66-8 | pseudo-Valinomycin(8CI,9CI); 1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,pseudo-valinomycin deriv.; Cyclo(D-a-hydroxyisovaleryl-L-alanyl-L-a-hydroxyisovaleryl-D-valyl-D-a-hydroxyisovaleryl-L-alanyl-L-a-hydroxyisovaleryl-D-valyl-D-a-hydroxyisovaleryl-L-alanyl-L-a-hydroxyisovaleryl-D-valyl); Cyclo(L-alanyl-L-a-hydroxyisovaleryl-D-valyl-D-a-hydroxyisovaleryl-L-alanyl-L-a-hydroxyisovaleryl-D-valyl-D-a-hydroxyisovaleryl-L-alanyl-L-a-hydroxyisovaleryl-D-valyl-D-a-hydroxyisovaleryl) | C54H90N6O18 | 详情 | 供应商 | ||
145918-65-6 | Propanediamide,N,N'',N''''-(1,3,5-benzenetriyltri-5,1-pentanediyl)tris[N'-heptyl-N'-methyl-(9CI); ETH 3832 | C54H96N6O6 | 详情 | 供应商 | ||
31616-96-3 | pseudo-retro-Valinomycin(8CI,9CI); 1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,pseudo-retro-valinomycin deriv.; Cyclo(L-alanyl-D-a-hydroxyisovaleryl-D-valyl-L-a-hydroxyisovaleryl-L-alanyl-D-a-hydroxyisovaleryl-D-valyl-L-a-hydroxyisovaleryl-L-alanyl-D-a-hydroxyisovaleryl-D-valyl-L-a-hydroxyisovaleryl); Cyclo(L-a-hydroxyisovaleryl-L-alanyl-D-a-hydroxyisovaleryl-D-valyl-L-a-hydroxyisovaleryl-L-alanyl-D-a-hydroxyisovaleryl-D-valyl-L-a-hydroxyisovaleryl-L-alanyl-D-a-hydroxyisovaleryl-D-valyl) | C54H90N6O18 | 详情 | 供应商 | ||
2001-95-8 | 缬氨霉素 | Valinomycin; 1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone,3,6,9,15,18,21,27,30,33-nonaisopropyl-12,24,36-trimethyl- (7CI); 1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane, cyclicpeptide deriv.; Cyclo(D-a-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-a-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-a-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl); NSC 122023; Valinomicin | C54H90N6O18 | 详情 | 供应商 | |
84559-93-3 | stearic acid, compound with N,N'-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]urea (2:1); stearic acid, compound with N,N'-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]urea (2:1); Einecs 283-180-5 | 无 | C55H92N6O5 | 详情 | 供应商 |